This trial is withdrawn!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Threatened Preterm Labor
and you are
3
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

This is a study for pregnant women who have been diagnosed with Threatened Preterm Labor. The principal aim of this study is to compare the efficacy and safety of Nifedipine treatment versus Atosiban treatment over these patients' newborn babies.

Provided treatments

  • Drug: Nifedipine
  • Drug: Atosiban

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01314859. The sponsor of the trial is Hospital Clinico Universitario de Santiago and it is looking for 0 volunteers for the current phase.
Official trial title:
ADMINISTRATION OF NIFIDEPINE VERSUS ATOSIBAN IN PREGNANT WOMEN WITH A THREAT OF PREMATURE LABOR